CLINICAL CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

4小时前 liuluofei 来自广东省

前往app查看评论内容

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2023-09-01 ms3000001344629820 来自陕西省

偏重的研究方向：深度学习;临床
经验分享：大家都来分享下，几天被拒的

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2023-06-30 ms4000000933785288 来自香港

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2023-01-12 ms8000001761301688 来自河南省

偏重的研究方向：肿瘤;临床
经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19

32 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2020-01-20 tomsyu

恭喜恭喜！gxjjbsbskdj 2019-12-12 发表::
接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表:
杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！

gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2022-01-29 灵动梦幻

请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢

224 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2021-07-15 幸运加满

偏重的研究方向：肿瘤
经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。

90 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2022-07-26 祝我好运

偏重的研究方向：临床及基础研究;Cancer
经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20

82 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2021-09-17 rayhuang_1003

估计要凉了，这么快的就进入了pending阶段，肯定拒稿
Stage Start Date
Decision Pending 2021-09-16 16:31:01
Under Review 2021-09-16 07:29:50
Under Editorial Consideration 2021-09-15 23:01:37
Initial QC 2021-09-14 13:24:49
Manuscript Submission 2021-09-14 11:33:22

264 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160746, encodeId=1f392160e465e, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kEOm2xpFyn0RkCw5lnnI6KKK6PWtPMibj3CIdhkMYCxSK5CUZgakH9ooXPVGJ6NPnhNRlr24Kich9110FQarLhdQ/132, createdBy=d9961627236, createdName=liuluofei, createdTime=Tue Oct 03 14:29:52 CST 2023, time=4小时前, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2155591, encodeId=f9372155591d5, content=偏重的研究方向：深度学习;临床 经验分享：大家都来分享下，几天被拒的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d905570358, createdName=ms3000001344629820, createdTime=Fri Sep 01 11:34:21 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2145676, encodeId=797621456e6d6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：这个杂志的Under Review 不一定代表就是送外审了，内审也会显示Under Review 。我们团队的Under Review 3天后被拒，收到的信息显示只是编辑部考虑了下，并没有送审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:28:06 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2109936, encodeId=aa12210993622, content=偏重的研究方向：肿瘤;临床 经验分享：同志们，见过这种吗？他这个under rev咋这么快，这应该是没送外审吧？ Under Review 2023-01-10 11:25:52 Under Editorial Consideration 2023-01-10 11:05:59 Initial QC 2023-01-08 08:14:19 Manuscript Submission 2023-01-08 04:16:19 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc968298560, createdName=ms8000001761301688, createdTime=Thu Jan 12 10:54:49 CST 2023, time=2023-01-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=583644, encodeId=341758364406, content=恭喜恭喜！gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！gxjjbsbskdj 2019-12-12 00:00:00 发表: 杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, beContent=gxjjbsbskdj 2019-12-12 发表:: 接收率：约25% 审稿时间：约1个月杂志审稿速度非常快，一审20天，会在编辑手里先审一下再送外审。审稿人的意见都能直接点出文章的问题，所以修改的时候一定要认真对待让审稿人看到诚意。二审也是编辑先审再送外审，同样20多天。很幸运被接收了，希望都好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Jan 20 00:00:00 CST 2020, time=2020-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189131, encodeId=924c1189131a0, content=请问各位科研大佬，Waiting for Potential Reviewer Assignment是指已经到了送审状态吗？麻烦请教下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Sat Jan 29 19:13:15 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999642, encodeId=6e35999642e8, content=偏重的研究方向：肿瘤 经验分享：请问大家怎么确定这个杂志是真外审还是假外审啊～感觉投稿都会有under review这个阶段，但是经常是假外审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210707/8fb772c5085640ef95993f5938a945b6/ffe9a19964c24876816fe18c8809fb71.jpg, createdBy=ba3a5543354, createdName=幸运加满, createdTime=Thu Jul 15 08:09:47 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234756, encodeId=72721234e569c, content=偏重的研究方向：临床及基础研究;Cancer 经验分享：这么快 Decision pending，凉凉了送审都很难啊…...Decision pending 两天了怎么还没有拒稿啊。快更新状态吧，好让我能抓紧投下一个杂志啊。 ———————————————————— Decision Pending 2022-07-24 08:37:02 Under Review 2022-07-21 11:09:34 Under Editorial Consideration 2022-07-19 18:45:50 Initial QC 2022-07-18 16:32:36 Manuscript Submission 2022-07-18 12:19:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaELz4jrEZgLqr5Eec2V9DMrPoBFjv0rrOnGDXsibA8ibd9ric0WRsVHOUoxMdNv3JESibAlYJes7tOK46g/132, createdBy=952e2441680, createdName=祝我好运, createdTime=Tue Jul 26 06:40:46 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052283, encodeId=55cf1052283fc, content=估计要凉了，这么快的就进入了pending阶段，肯定拒稿 Stage Start Date Decision Pending 2021-09-16 16:31:01 Under Review 2021-09-16 07:29:50 Under Editorial Consideration 2021-09-15 23:01:37 Initial QC 2021-09-14 13:24:49 Manuscript Submission 2021-09-14 11:33:22, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06ca5577390, createdName=rayhuang_1003, createdTime=Fri Sep 17 10:55:26 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216991, encodeId=6016121699155, content=这个期刊怎么注册呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55846424558, createdName=ms2000000903653686, createdTime=Thu May 05 09:56:11 CST 2022, time=2022-05-05, status=1, ipAttribution=)]

2022-05-05 ms2000000903653686

这个期刊怎么注册呀？

2 0

内科

外科

专科科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务